Arkolith/Insider Trading/INVO/Form 4

Goren Andrea

Chief Financial OfficerINVO Bioscience, Inc. (INVO) · full profile →Form 4 · filed Oct 7, 2021
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 5, 2021Buy(P)31K$3.26$100K76K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-024951) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML